1	National Disease and Therapeutic Index (NDTI) :   Plymouth Meeting, Pa : IMS Health; August, 2001.
	2	Uhlenhuth, E. H. et al.: Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997, Europen Neuropsychopharmacol. 9 (Suppl. 6) S393-S398, 1999.
	3	Gorman, J. M. et al.: Neuroanatomical hypothesis of panic disorder   [revised], Am. J. Psychiatry.157, 493-505, 2000.
	4	Stahl, S. M. et al.: Independent Actions on Fear Circuits May Lead to Therapeutic Synergy for Anxiety When Combining Serotonergic and GABAergic Agents, J. Clin. Psychiatry. 63 (10) 854-855, 2002.
	5	Goddard, A. W., Brouette, T., Almai, A. et al.: Early Coadministration of Clonazepam with Sertraline for Panic Disorder, Arch. Gen. Psychiatry. 58, 681-686, 2001.
	6	Ballenger, J. C. et al. : Consensus Statement on Panic disorder From the International Consensus Group on Depression and Anxiety, J. Clin. Psychiatry. 59 (Suppl. 8) 47-54, 1998.
	7	Pollack,  M. H. et al.: Social Anxiety Disorder : Designing a Pharmacologic Treatment Straregy, J. Clin. Psychiatry. 60,  20-26, 1999.
	8	Woods, S. W., Nagy, L. M., Kolesar, A. S. et al. : Controlled trial of aiprazolam supplementation during imipramine treatment of panic disorder, J. Clin. Psychopharmacol. 12, 32-38, 1992.
	9	Dannon, P. N., Iancu, I., Gruhaus, L. J. et al.: Short-term Potentiation of Paroxetine with Clonazepam in the Treatment of Patients with Panic Disorder : American Psychiatry Association Annual Meeting, Washington, DC, May 15-29, 1999. Washington, DC : American Psychiatry Association Press, p.153, 1999.
	10	Kaiya, H.: Panic Disorder and Generalized Anxiety Disorder: TODAY'S THERAPY 2002 (44) 618-619, 2002.
	11	Motohashi, N. : Development of revised algorithm for the treatment mood disorders in Japan, XII WCP (Yokohama) S-108-1, 2002.
	12	Herman, J. B. : et al. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines, J. Clin. Psychiatry. 48, 22, 1987.
	13	Hallfors, D. D. et al. : The dependence potential of short harf-life benzodiazepines : A meta-analysis, Am. J. Public Health 83, 1300-1304, 1993.
	14	Nelson, J. et al. : Guidelines for the clinical use of benzodiazepines : Pharmacokinetics, dependency, rebound and withdrawal, Can. J. Clin. Pahrmacol. 6 (2) 69-83, 1999.
	15	The Royal College of Psychiatrists : CR59, Benzodiazepines : risks, benefits and dependence A re-evaluation, Council Report CR 59 January 1997. Royal College of Paychiatrists, London, 1997.